DDBB1D1 Evera XT
Implantable Cardioverter Defibrillator (ICD)
DDBB1D1 Evera XT
Information

Device Survival Probability

EVERA_DR_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr at 136.0 mo                  
% Excluding Normal Battery Depletion 100.0 100.0 100.0 99.9 99.9 99.9 99.8 99.8 99.7 99.7 99.7 99.7                  
% Including Normal Battery Depletion 99.9 99.9 99.8 99.7 99.5 99.1 98.0 95.2 90.5 78.8 48.7 29.5                  
#   218957 205673 190688 171777 153886 131552 104487 76012 48386 22276 4041 568                  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type ICD
NBD Code DDE-DDDR
Max. Delivered Energy 36 J
More
Connector Style DR Style
Serial Number Prefix BWC
Mass 77 g
Volume 33 cc
Waveform Biphasic
X-Ray ID PXT
Hide this content
DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.1 4.6 5.1 5.4
Quarterly 5.9 7.0 8.3 9.0
Semi-annual 6.2 7.6 9.0 9.8
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2013-04-03
CE Approval Date
Registered USA Implants43054
Estimated Active USA Implants15524
Normal Battery Depletions3127
US Market Release2013-04-03
CE Approval Date
Estimated WW Distribution44690
Normal Battery Depletions3128
Information

Malfunctions (USA)

Therapy Function Not Compromised 60
Battery 36
Electrical Component 21
Software/Firmware 1
Other 2
Therapy Function Compromised 36
Battery 31
Device-Related Current Pathway 1
Electrical Component 2
Electrical Interconnect 1
Other 1
Information

Malfunctions (WW)

Therapy Function Not Compromised 61
Battery 36
Electrical Component 21
Software/Firmware 1
Other 3
Therapy Function Compromised 36
Battery 31
Device-Related Current Pathway 1
Electrical Component 2
Electrical Interconnect 1
Other 1
Information

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.73V on 3 consecutive daily automatic measurments.

Information

Charge Time

BLACKWELL_DR_CHRG
Loading...

Data as of June 8, 2026

www.medtronic.com/productperformance 22521